Evercore ISI upgraded Clorox's stock rating from "Underperform" to "In Line" and set a $99 price target. This indicates a moderately improved analyst outlook for the company, potentially leading to some positive short-term trading interest.
Evercore ISI upgraded The Clorox Company's stock rating from "Underperform" to "In Line" and established a $99 price target. This analyst action signals a more neutral, rather than negative, outlook on Clorox's performance. While not a strong 'Buy' recommendation, moving from 'Underperform' suggests that the firm sees fewer downside risks or improved fundamentals. This could lead to a modest positive sentiment shift for CLX in the short term, potentially attracting some buying interest from investors who follow analyst ratings. The long-term impact is likely limited unless followed by further positive catalysts, but it removes a previous negative overhang.